United States · FDA National Drug Code directory

OMNIPAQUE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0407-1412_61f3e388-89bf-43d6-ad51-b620fff561fb
Product NDC
0407-1412
Form
INJECTION, SOLUTION
Composition / generic term
Iohexol
Labeler
GE Healthcare Inc.
Marketing category
NDA
Marketing start / end (source format)
19851226
Source listing expiry
20271231

Source-listed ingredients

  • IOHEXOL — 240 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 VIAL, GLASS in 1 BOX (0407-1412-10) / 10 mL in 1 VIAL, GLASS · 0407-1412-10
  • 10 VIAL, GLASS in 1 BOX (0407-1412-20) / 20 mL in 1 VIAL, GLASS · 0407-1412-20
  • 10 BOTTLE, PLASTIC in 1 BOX (0407-1412-30) / 50 mL in 1 BOTTLE, PLASTIC · 0407-1412-30
  • 10 BOTTLE, PLASTIC in 1 BOX (0407-1412-33) / 100 mL in 1 BOTTLE, PLASTIC · 0407-1412-33

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →